# Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy

> **NCT01514721** · PHASE4 · TERMINATED · sponsor: **Alcon Research** · enrollment: 37 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Travoprost/Timolol Maleate BAK-Free Fixed Combination

## Key facts

- **NCT ID:** NCT01514721
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514721, "Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01514721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*